Eighth Patient Treated with Sealantis Novel Alga-Mimetic Sealant

Sealantis Ltd., a private start-up from the Technion-Israel Institute of Technology, reports that an eighth patient was treated with Seal-V, its alga-mimetic vascular sealant, as part of the company’s first clinical study. Seal-V is a protein-free sealant, designed to resolve current limitations and challenges in control of surgical bleeding. It is expected to receive CE Mark within the year.

Eighth Patient Treated with Sealantis Novel Alga-Mimetic Sealant (via PR Newswire)

Sealantis Conveys Nature’s Power to Prevent Dangerous Leakage of Bodily Fluids HAIFA, Israel, June 27, 2013 /PRNewswire/ — Sealantis Ltd., a private start-up from the Technion-Israel Institute of Technology, reports that an eighth patient was treated…

published: June 28, 2013 in: News, Technology

Most read

Latest

^